Target Price | $139.93 |
Price | $133.45 |
Potential | 4.86% |
Number of Estimates | 30 |
30 Analysts have issued a price target Arm 2026 . The average Arm target price is $139.93. This is 4.86% higher than the current stock price. The highest price target is $180.00 34.88% , the lowest is $80.00 40.05% . | |
A rating was issued by 40 analysts: 24 Analysts recommend Arm to buy, 13 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2026 of 4.86% . Most analysts recommend the Arm stock at Purchase. |
34 Analysts have issued a sales forecast Arm 2026 . The average Arm sales estimate is $4.8b . This is 19.31% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.1b 26.43% , the lowest is $4.6b 14.73% .
This results in the following potential growth metrics:
2025 | $4.0b | 23.94% |
---|---|---|
2026 | $4.8b | 19.31% |
2027 | $5.8b | 22.09% |
2028 | $7.0b | 19.22% |
2029 | $8.0b | 15.22% |
2030 | $9.3b | 16.60% |
19 Analysts have issued an Arm EBITDA forecast 2026. The average Arm EBITDA estimate is $2.3b . This is 125.41% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.8b 175.44% , the lowest is $1.4b 35.70% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $1.0b | 288.51% |
---|---|---|
2026 | $2.3b | 125.41% |
2027 | $2.9b | 27.77% |
2028 | $4.1b | 40.68% |
2029 | $4.5b | 8.88% |
2030 | $5.2b | 17.32% |
2025 | 25.31% | 213.46% |
---|---|---|
2026 | 47.81% | 88.93% |
2027 | 50.03% | 4.64% |
2028 | 59.04% | 18.01% |
2029 | 55.79% | 5.50% |
2030 | 56.13% | 0.61% |
19 Arm Analysts have issued a net profit forecast 2026. The average Arm net profit estimate is $1.1b . This is 38.83% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.7b 110.67% , the lowest is $328m 58.67% .
This results in the following potential growth metrics and future Net Margins:
2025 | $793m | 158.62% |
---|---|---|
2026 | $1.1b | 38.83% |
2027 | $1.7b | 55.72% |
2028 | $2.4b | 38.64% |
2029 | $3.2b | 36.12% |
2030 | $3.9b | 21.73% |
2025 | 19.78% | 108.67% |
---|---|---|
2026 | 23.02% | 16.36% |
2027 | 29.36% | 27.54% |
2028 | 34.15% | 16.31% |
2029 | 40.34% | 18.13% |
2030 | 42.12% | 4.41% |
19 Analysts have issued a Arm forecast for earnings per share. The average Arm EPS is $1.04 . This is 38.67% higher than earnings per share in the financial year 2025. The highest EPS forecast is $1.58 110.67% , the lowest is $0.31 58.67% .
This results in the following potential growth metrics and future valuations:
2025 | $0.75 | 158.62% |
---|---|---|
2026 | $1.04 | 38.67% |
2027 | $1.62 | 55.77% |
2028 | $2.25 | 38.89% |
2029 | $3.06 | 36.00% |
2030 | $3.73 | 21.90% |
Current | 179.10 | 53.05% |
---|---|---|
2026 | 128.17 | 28.44% |
2027 | 82.30 | 35.79% |
2028 | 59.36 | 27.87% |
2029 | 43.61 | 26.53% |
2030 | 35.83 | 17.84% |
Based on analysts' sales estimates for 2026, the Arm stock is valued at an EV/Sales of 28.99 and an P/S ratio of 29.51 .
This results in the following potential growth metrics and future valuations:
Current | 34.58 | 1.14% |
---|---|---|
2026 | 28.99 | 16.17% |
2027 | 23.74 | 18.09% |
2028 | 19.92 | 16.12% |
2029 | 17.28 | 13.21% |
2030 | 14.82 | 14.24% |
Current | 35.20 | 0.51% |
---|---|---|
2026 | 29.51 | 16.18% |
2027 | 24.17 | 18.09% |
2028 | 20.27 | 16.12% |
2029 | 17.59 | 13.21% |
2030 | 15.09 | 14.23% |
Analyst | Rating | Action | Date |
---|---|---|---|
Loop Capital |
Buy
➜
Buy
|
Unchanged | May 13 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
Benchmark |
Hold
➜
Hold
|
Unchanged | May 08 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
Guggenheim |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Loop Capital:
Buy
➜
Buy
|
May 13 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
May 08 2025 |
Unchanged
Benchmark:
Hold
➜
Hold
|
May 08 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
May 08 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 08 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
May 08 2025 |
Unchanged
Guggenheim:
Buy
➜
Buy
|
May 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.